Why Abbott Laboratories (ABT) Surged On Thursday?
From Yahoo Finance: 2025-03-28 04:27:00
On Thursday, the stock market saw losses as investors reacted to global trade tensions. The Nasdaq fell 0.53%, Dow Jones dropped 0.37%, and S&P 500 declined by 0.33%. Automaker shares were hit hard by President Trump’s announcement of a 25% tariff on imported vehicles.
Despite the market decline, 10 companies stood out with gains. Two gold miners attracted investors seeking safer assets. The top performers defied market pessimism due to positive company developments.
Abbott Laboratories (ABT) surged 3.74% to $131.35 after an “outperform” rating and $134 price target from Oppenheimer. The CE Mark approval for its Volt PFA catheter in Europe boosted investor sentiment. Approval in the US is expected between this year and 2026.
The early CE Mark approval for Abbott’s catheter in Europe may accelerate FDA approval timeline. ABT ranks 8th in the list of stocks that defied market uncertainties. While ABT shows promise, some AI stocks may offer higher returns in a shorter time frame.
Read more at Yahoo Finance: Why Abbott Laboratories (ABT) Surged On Thursday?